CHA
GMED icon

Carmichael Hill & Associates’s Globus Medical GMED Stock Holding History

Carmichael Hill & Associates’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Hold
0
– -$24K – 812
2022
Q3 		– Hold
0
– – – 440
2022
Q2 		– Hold
0
– – – 451

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Carmichael Hill & Associates's GMED Position: Q1 2024 in Review

Carmichael Hill & Associates sold out of Globus Medical (GMED) in Q1 2024, closing a stake of 300 shares — an estimated $16K sold.

Carmichael Hill & Associates first reported a position in GMED in Q2 2020 and held it in 15 quarters. The position peaked at $54K in Q3 2021. 439 funds tracked by Wall St. Rank hold GMED as of Q1 2024.

  • Carmichael Hill & Associates reported no remaining Globus Medical position as of Q1 2024 after selling out during the quarter.
  • Carmichael Hill & Associates sold 300 Globus Medical shares in Q1 2024, an estimated $16K.
  • Carmichael Hill & Associates first reported a position in Globus Medical in Q2 2020 and held it in 15 quarters.
  • Carmichael Hill & Associates's Globus Medical position peaked at $54K in Q3 2021.
  • 439 funds tracked by Wall St. Rank held Globus Medical as of Q1 2024.

Based on Carmichael Hill & Associates's 13F filing for Q1 2024, filed 24 Apr 2024.